Implementing a structured ISO 14971 FMEA Risk Scoring process is essential for evaluating supplier modifications under ISO 13485.
When a raw material or component supplier issues a Supplier Change Notification (SCN), quality engineers face a high-stakes challenge: proving that the modification won’t introduce hidden failure modes into medical device manufacturing.
In medical device quality management under ISO 13485 and ISO 14971, relying on historical, static “Low” Risk Priority Numbers (RPN) is one of the leading causes of audit non-conformances during notified body inspections. When a supplier alters a resin grade, molding cycle time, or masterbatch additive, subtle shifts in tensile yield, cure rates, or particulate generation can completely invalidate legacy risk assumptions.
This guide provides a standardized 1โ10 FMEA risk scoring scale tailored for ISO 14971 compliance, along with a 5-point evaluation checklist to audit supplier changes effectively.
ISO 14971 Risk Scoring Reference Scale (1โ10 Definitions)
How to Execute ISO 14971 FMEA Risk Scoring for Supplier Changes
To satisfy FDA and notified body auditors, risk scoring criteria must be strictly defined, documented, and applied consistently across all Design (DFMEA) and Process (PFMEA) evaluations prior to executing risk files.
| Lvl | Severity (S) โ Harm / Impact | Occurrence (O) โ Probability | Detection (D) โ Control Effectiveness |
|---|---|---|---|
| 1 | No Effect โ No impact on device function | Remote โ < 1 in 100,000 | Very High โ Defect almost certain to be detected |
| 2 | Minor โ Slight performance degradation | Very Low โ 1 in 50,000 to 100,000 | Very High โ Defect very likely to be detected |
| 3 | Low โ Noticeable effect but manageable | Low โ 1 in 10,000 to 50,000 | High โ Defect likely to be detected |
| 4 | Moderate โ Significant performance reduction | Low-Medium โ 1 in 1,000 to 10,000 | High โ Defect probably will be detected |
| 5 | Medium โ Serious functional impairment | Medium โ 1 in 100 to 1,000 | Moderate โ Defect may or may not be detected |
| 6 | High โ Major impact on functionality | Medium-High โ 1 in 50 to 100 | Moderate โ Defect probably will not be detected |
| 7 | Very High โ Critical functional loss | High โ 1 in 10 to 50 | Low โ Defect unlikely to be detected |
| 8 | Severe โ Potential for temporary harm | Very High โ 1 in 5 to 10 | Very Low โ Defect very unlikely to be detected |
| 9 | Critical โ Potential for serious injury | Very High โ 1 in 2 to 5 | Very Low โ Defect almost never detected |
| 10 | Fatal / Irreversible โ Death or permanent harm | Extremely High โ > 1 in 2 | No Detection โ No control to detect defect |
💡 Need an Audit-Ready ISO 14971 Risk Management System?
Stop wrestling with unlinked spreadsheets. Streamline your entire risk file with the enterprise ISO 14971 FMEA Risk Management System from Quality Doc Hub. Features dynamic RPN heatmaps, automated risk scoring, residual risk acceptability tracking, and pre-loaded medical device worked examples.
Supplier Change FMEA Audit Checklist (5 Critical Risk Checks)
When a supplier modifies a raw material, process parameter, or manufacturing site, use this 5-point checklist before closing out your risk review:
1. Material Grade & Additive Shift Analysis
Verify whether raw material suppliers, polymer grade additives, masterbatch pigments, or resin suppliers changed. Evaluate downstream impacts on biocompatibility, cure rates, particulate generation, and tensile yield shifts.
2. Processing Parameter & Dimensional Drift
Assess changes in injection molding cycle times, sterilization parameters, or machining tolerances. Determine if downstream receiving inspection is actually capable of detecting these subtle physical changes.
3. ISO 14971 Hazard Sequence Re-evaluation
Re-evaluate the full hazard chain: Hazard โ Hazardous Situation โ Harm. Update Severity, Occurrence, and Detection scores using standardized 1โ10 definitions rather than guessing baseline scores.
4. Design Verification & Validation (V&V) Impact
Determine whether the supplier’s modification invalidates existing shelf-life stability data, transit testing, electrical safety, or biocompatibility test protocols.
5. Closed-Loop Documentation & Change Control
Ensure updated risk assessments are officially linked to your Change Order (ECN/DCO) package and ready for inspection during your next internal or notified body audit.
By maintaining consistent ISO 14971 FMEA Risk Scoring across all supplier changes, you keep your QMS audit-ready and fully compliant.
Conclusion & Next Steps
Relying on legacy FMEA scores when suppliers change raw materials creates massive audit liabilities. By standardizing your 1โ10 scoring scales and executing closed-loop risk reviews, your quality team remains fully compliant under ISO 13485 and ISO 14971 requirements.
For more compliance templates and QMS toolkits built specifically for regulated medical device environments, explore the full resource library at QualityDocHub.com.
Surviving audit season? Check out our ‘Approved Protocol, Unapproved Reality’ mug & desk art collection at Charcoal Command Studio.
Leave a Reply